SLC34A3

solute carrier family 34 member 3, the group of Solute carrier family 34

Basic information

Region (hg38): 9:137230757-137236555

Links

ENSG00000198569NCBI:142680OMIM:609826HGNC:20305Uniprot:Q8N130AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary hypophosphatemic rickets with hypercalciuria (Supportive), mode of inheritance: AR
  • hereditary hypophosphatemic rickets with hypercalciuria (Strong), mode of inheritance: AR
  • hereditary hypophosphatemic rickets with hypercalciuria (Definitive), mode of inheritance: Semidominant

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hypophosphatemic rickets with hypercalciuria, hereditaryARRenalThe condition can result in sequelae such as severe rickets, and supplementation (eg, with phosphate) can be effective to treat many sequelaeRenal2983203; 3796683; 1436310; 16358214; 16358215
Heterozygotes may show mild manifestations

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC34A3 gene.

  • not_provided (562 variants)
  • Autosomal_recessive_hypophosphatemic_bone_disease (311 variants)
  • Inborn_genetic_diseases (122 variants)
  • SLC34A3-related_disorder (69 variants)
  • not_specified (37 variants)
  • Kidney_disorder (3 variants)
  • Hypercalciuria (1 variants)
  • Hypophosphatemic_nephrolithiasis/osteoporosis_1 (1 variants)
  • Nephrolithiasis/nephrocalcinosis (1 variants)
  • Retinitis_pigmentosa_59 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC34A3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001177316.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
11
clinvar
157
clinvar
4
clinvar
173
missense
4
clinvar
13
clinvar
310
clinvar
25
clinvar
3
clinvar
355
nonsense
5
clinvar
11
clinvar
3
clinvar
19
start loss
2
2
frameshift
17
clinvar
15
clinvar
5
clinvar
37
splice donor/acceptor (+/-2bp)
4
clinvar
22
clinvar
2
clinvar
1
clinvar
1
clinvar
30
Total 31 63 331 183 8

Highest pathogenic variant AF is 0.00072278

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC34A3protein_codingprotein_codingENST00000538474 125798
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.89e-140.029812548612121256990.000848
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.294663941.180.00002713758
Missense in Polyphen188166.581.12861678
Synonymous-3.272511931.300.00001481367
Loss of Function0.2152122.10.9510.00000105222

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001230.00120
Ashkenazi Jewish0.000.00
East Asian0.0003310.000326
Finnish0.001150.00111
European (Non-Finnish)0.001170.00111
Middle Eastern0.0003310.000326
South Asian0.0006240.000588
Other0.0008330.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. Probably mediates 20-30% of the apical influx.;
Disease
DISEASE: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530]: Autosomal recessive form of hypophosphatemia characterized by reduced renal phosphate reabsorption and rickets. Increased serum levels of 1,25-dihydroxyvitamin D lead to increase in urinary calcium excretion. {ECO:0000269|PubMed:16358214, ECO:0000269|PubMed:16358215}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Type II Na+/Pi cotransporters;Sodium-coupled phosphate cotransporters (Consensus)

Recessive Scores

pRec
0.173

Intolerance Scores

loftool
0.239
rvis_EVS
0.41
rvis_percentile_EVS
76.54

Haploinsufficiency Scores

pHI
0.152
hipred
N
hipred_score
0.170
ghis
0.418

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.770

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc34a3
Phenotype
renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
sodium ion transport;phosphate ion transport;cellular phosphate ion homeostasis;sodium ion transmembrane transport;sodium-dependent phosphate transport
Cellular component
plasma membrane;brush border;integral component of membrane;apical plasma membrane;brush border membrane;vesicle
Molecular function
sodium:phosphate symporter activity;sodium-dependent phosphate transmembrane transporter activity